Learning outcomes
By the end of this lesson you should be able to: describe melanogenesis, the transfer of melanin to keratinocytes and the fate of the melanosome; classify the Fitzpatrick skin types and explain sun-protection measures by type; recognise vitiligo, distinguish segmental from non-segmental disease, describe its systemic associations and outline its treatment; recognise melasma, distinguish epidermal, dermal and mixed types on Wood lamp examination, and explain photoprotection and the role of the triple-combination cream; recognise post-inflammatory hyper- and hypopigmentation, pityriasis alba and ash dermatosis; and describe the drug- and metal-induced pigmentary states and exogenous ochronosis.
Prerequisites
Lesson 1 (the melanocyte and the epidermal melanin unit), Lesson 2 (the Wood lamp) and Lesson 6 for post-inflammatory pigment change after eczema.
The big idea
Because pigment depends on a chain — production in the melanocyte, transfer to the keratinocyte, transport up the epidermis, and eventual shedding — a disorder at any link produces a colour change. Loss of melanocytes produces depigmentation (vitiligo); reduced production gives hypopigmentation (pityriasis alba); increased production and transfer give hyperpigmentation (melasma, lentigines); pigment left behind after inflammation gives post-inflammatory change; and pigment deposited in the dermis from a drug or from a metal is stubborn, because macrophages have no easy route of exit. Ask where in the chain the problem sits, and you will know which disorders are reversible and which are not.
NoteFitzpatrick phototypes I to VI classify by response to sun rather than by colour, and they matter for two decisions: sun-protection advice and the risk of post-inflammatory hyperpigmentation after any procedure. Types V and VI — brown and black skin — develop visible post-inflammatory pigment change from lesions that are invisible in type I, which is why they should be managed with the least abrasive methods and why ablative lasers are hazardous in them.
Vitiligo
| Type | Features |
|---|---|
| Non-segmental (common) vitiligo | Acquired, sharply demarcated, chalk-white, completely depigmented macules that enlarge, coalesce and often respect a symmetric or acrofacial distribution (around the eyes, mouth, digits, extensor surfaces); the Koebner phenomenon appears at sites of friction or trauma; hair within a lesion may depigment. Fluorescence sharply demarcated under Wood lamp |
| Segmental vitiligo | A unilateral band following a dermatome or a Blaschko line, appearing in childhood, progressing for about a year and then remaining stable — the type most suitable for surgical repigmentation |
| Universal vitiligo | Extensive loss over the whole or nearly the whole body, sometimes with a little pigment left at follicles or in a naevus |
The pathogenesis is a cell-mediated autoimmune destruction of melanocytes, driven by CD8 T cells through interferon-gamma and the CXCL10 pathway, in a genetically susceptible individual; a convergence theory adds oxidative stress, a neural factor and intrinsic melanocyte fragility as contributing elements. The autoimmune links are the clinical point: screen for thyroid disease (Hashimoto thyroiditis, Graves disease) with thyroid function and antibodies, and for pernicious anaemia, type 1 diabetes, Addison disease and alopecia areata, because they travel together.
| Treatment | Indication and expectation |
|---|---|
| Topical corticosteroid or topical calcineurin inhibitor | First-line for limited disease and for the face; a calcineurin inhibitor is preferred on eyelids and facial skin because it does not atrophy. Repigmentation begins at the follicular openings after 3 to 6 months |
| Narrow-band UVB phototherapy | Second-line for widespread disease, two to three times weekly for 6 months and more in dark-skinned patients; the most reliable medical repigmentation |
| Oral mini-pulse steroids | Betamethasone or dexamethasone on two consecutive days a week for rapidly progressing disease |
| Surgical transplantation | Autologous melanocyte suspensions, suction blister grafts or punch grafts, for stable segmental or stable non-segmental disease of more than a year |
| Depigmentation | Monobenzone or laser for universal or extensive disease, converting residual pigment to a uniform white |
| Camouflage and counselling | Cosmetic camouflage, self-tanning creams and tattooing of stable lesions, together with the psychological support that is often the most valuable part of care |
Watch outTreating a hypopigmented patch as vitiligo. Vitiligo is depigmented — milk-white and fluorescent on Wood lamp — and complete depigmentation with a lost scale means an absence of melanocytes. Pityriasis alba, pityriasis versicolor, post-inflammatory hypopigmentation and naevus depigmentosus are hypopigmented, not depigmented, and they behave and respond quite differently.
Melasma
| Feature | Detail |
|---|---|
| Presentation | Symmetric, blotchy, brown or grey-brown hyperpigmentation of the face — the centrofacial pattern (forehead, cheeks, upper lip, nose and chin) is commonest, with malar and mandibular alternatives. Almost entirely women of Fitzpatrick types III to VI between 20 and 40 |
| Triggers | Sunlight (the strongest), pregnancy (chloasma, the mask of pregnancy, fading months after delivery), oestrogen-containing contraception and hormone replacement, and genetics; pigment is produced by increased melanocyte activity and increased melanosome transfer into all epidermal layers plus dermal melanophages |
| Wood lamp typing | Epidermal melasma is enhanced by Wood lamp and responds to treatment; dermal melasma is not enhanced and is largely resistant; mixed melasma is the commonest type in darker skin; in very dark skin lamp examination is uninformative |
| Treatment | Strict photoprotection with a broad-spectrum high-SPF sunscreen, reapplied and combined with a tinted product containing iron oxides to block visible light; a triple combination of hydroquinone 4 per cent, tretinoin and a moderate topical steroid for 3 to 4 months, then stepping down to hydroquinone alone or to azelaic acid, kojic acid or vitamin C; oral tranexamic acid in selected cases; chemical peels and lasers only with care, because they can worsen the pigmentation in dark skin |
| Counselling | Recurrence is the rule after stopping, and the goal is control rather than cure; prolonged or unmonitored hydroquinone causes exogenous ochronosis — paradoxical blue-black hyperpigmentation, particularly on the malar prominences of darker-skinned women |
Other pigmentary disorders
| Condition | Mechanism and picture |
|---|---|
| Post-inflammatory hyperpigmentation | Inflammation in the epidermis spills melanin into the dermis where it is taken up by macrophages; it follows acne, eczema, lichen planus, fixed drug eruptions, herpes and overly aggressive cosmetic procedures, and is worst in pigmented skin. Treated by treating the inflammation, sun protection, and time; topical retinoids, azelaic acid or hydroquinone help |
| Post-inflammatory hypopigmentation and pityriasis alba | Reduced melanin in an inflamed patch, with ill-defined scaly patches on the faces and arms of atopic children; emollient, mild topical steroid and sun exposure are beneficial |
| Progressive macular hypomelanosis | Hypopigmented macules on the trunk of young adults with Propionibacterium acnes producing a factor that suppresses melanogenesis; coral-red fluorescence under Wood lamp; treated by topical or oral antimicrobials and ultraviolet exposure |
| Café-au-lait macule | Uniform light-brown oval patch. Six or more larger than 5 mm before puberty (15 mm after) points to neurofibromatosis type 1; the irregular coast-of-Maine border with bony disease points to McCune-Albright syndrome |
| Freckles and lentigines | A freckle (ephelis) is increased melanin in the basal layer without increased melanocyte number, and fades in winter; a lentigo has an elongated rete and increased melanocytes, and does not fade. Solar lentigines of the hands and face respond to cryotherapy, laser or retinoid |
| Ash dermatosis and idiopathic guttate hypomelanosis | Ashy-grey macules on the trunk of darker-skinned adults (the former) and small porcelain-white macules on the shins of the elderly (the latter) |
| Addison disease (adrenal insufficiency) | Diffuse hyperpigmentation of sun-exposed and pressured skin, with buccal and palmar crease pigmentation and darkening of scars, from excess adrenocorticotrophic hormone peptides |
| Drug- and metal-induced pigmentation | Minocycline gives blue-grey discoloration of scars and shins and sometimes the sclerae; amiodarone gives slate-grey pigmentation on exposed skin with phototoxicity; clofazimine gives red-brown skin; chloroquine and hydroxychloroquine give grey pigmentation on the pretibial skin with retinopathy; phenothiazines give blue-grey exposed discoloration; silver gives argyria and gold gives chrysiasis; carotenoids in diet or in hypothyroidism give orange palms and soles with sclera spared — and the sparing of the sclera distinguishes carotenoderma from jaundice |
| Exogenous ochronosis | Paradoxical blue-black hyperpigmentation of the malar skin after prolonged or unmonitored use of hydroquinone or other phenols, particularly in Fitzpatrick types V and VI; avoidable by limiting hydroquinone to fixed courses |
| Poikiloderma of Civatte | Reticulate erythema and pigmentation of the sides of the neck and cheeks with sparing of the shaded submental triangle, from chronic photodamage in middle-aged women |
Common mistakes
Watch outTreating melasma with laser as a first-line treatment. Heat in dark skin stimulates the melanocyte and worsens the pigmentation, so laser is a late and cautious option; strictly protected sunscreen, topical agents and patience are the standard of care.
Watch outPrescribing hydroquinone indefinitely. Use it in defined courses of 3 to 4 months, monitor and stop, because prolonged use risks exogenous ochronosis — a hyperpigmentation that is far harder to treat than the melasma it replaced.
Watch outMissing a systemic cause. Diffuse hyperpigmentation with buccal and crease pigmentation is Addison disease; photosensitivity with lentigines before the age of two is xeroderma pigmentosum; and pigment change with weight change and fatigue is thyroid disease. Vitiligo is not isolated — screen the thyroid, blood count and glucose.
Watch outConfusing carotenoderma with jaundice. In carotenoderma the yellow discoloration is on the palms, soles, knees and nasolabial folds and the sclerae are white, whereas jaundice yellowsthe sclerae first and spares the palms. A skin-fold examination costs nothing and settles it.
Check your understanding
A patient has the visceral features of adrenal insufficiency. What cutaneous sign would make you suspect Addison disease, and why does it appear?
Which light examination distinguishes vitiligo from pityriasis alba, and what does each show?
Why is a tinted sunscreen recommended over a plain one in melasma?
Multiple choice
Which statement about vitiligo is correct?
Which finding best supports a diagnosis of melasma?
A patient develops a diffuse slate-grey discoloration of her scars and shins after a 6-week course of antibiotics for acne. Which drug is most likely responsible?
Which statement about the management of melasma is correct?
Summary and next
Pigment disorders are disorders of a chain: production, transfer, transport and shedding. Vitiligo is autoimmune depigmentation, treated with topical anti-inflammatories, narrow-band UVB and, in stable disease, transplantation, and screened for thyroid and other autoimmune disease. Melasma is sun- and hormone-driven hyperpigmentation, managed by strict photoprotection and topical triple combination therapy with strict time limits. Post-inflammatory pigment change is worst in dark skin, drug and metal pigment deposition is permanent, and exogenous ochronosis is the avoidable consequence of too much hydroquinone.
Next: the genodermatoses and the cutaneous signs of HIV. Here the genes are structural proteins of skin, each defect maps to a layer, and the skin lesions are often the first sign of a systemic disease — which is precisely why they must be recognised.